XML 26 R11.htm IDEA: XBRL DOCUMENT v3.25.3
Accounting Changes and Error Corrections
12 Months Ended
Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
Accounting Standards Update and Change in Accounting Principle Restatement of Previously Issued Consolidated Financial Statements
The Company has restated its consolidated financial statements for the fiscal years ended December 31, 2024, 2023 and 2022 below. Additionally, the "As Reported" Consolidated Balance Sheet in this Note C for the years ended December 31, 2022 has been recast to reflect the effect of the sale of EBP Lifestyle Brands Holdings, Inc. during the fourth quarter of 2024. Additionally, based on the consolidated financial information included within the Company's previously filed financial statements in the Original Filing, the Company was in compliance with the 2022 Credit Facility’s financial covenants in each of these periods. However, in retrospectively testing financial covenant compliance under the 2022 Credit Facility in each of the Affected Periods in reliance on the restated consolidated financial information provided in this Form 10-K/A, the Company would not have been in compliance with such financial covenants as of the years ended December 31, 2024 and 2023. As a result, the 2022 Term Loan and 2022 Revolving Credit facility that were previously classified as long-term debt in the consolidated balance sheet at each of these periods in the As Reported financial information have been reclassified to current portion of long-term debt in the accompanying balance sheets in this footnote for the periods in which the Company was not in compliance with the financial covenants in the 2022 Credit Facility. Additionally, because the 2029 Notes and 2032 Notes may have been subject to acceleration had the lenders under the 2022 Credit Facility exercised their acceleration rights
during such historical periods, the 2029 Notes and 2032 Notes are also being reclassified to current portion of long-term debt in such accompanying balance sheets.
The impact of the correction of the misstatements and errors described in Note B on the Consolidated Statements of Cash Flows were driven by changes in the related Consolidated Balance Sheet and Consolidated Statement of Operations line items. Below is a summary description of the significant errors:

Consolidated Balance Sheets
ADJ 1Accounts Receivable - amounts were recorded at Lugano as accounts receivable which did not represent activity associated with a valid revenue transaction.
ADJ 2Inventory and Other Current Assets - amounts were recorded at Lugano as purchases of inventory or vendor prepayments which did not represent valid purchases. Invalid inventory transactions were also recorded in connection with barter purchases of jewelry or gems from customers in exchange for reducing accounts receivable transactions, and in connection with invalid revenue transactions. Other current assets increased as a result of the revised Lugano tax provision and a tax receivable that was recorded in each of the years presented in the consolidated financial statements.
ADJ 3Goodwill and Intangible Assets - the purchase price allocation of the assets acquired and liabilities assumed in the acquisition of Lugano in September 2021 was based upon materially incorrect financial information. As a result, the Company re-performed the purchase price allocation, which resulted in a change in the fair value of the intangible assets acquired and the calculation of goodwill. Additionally, due to the adjustments to historical financial information that resulted from the Lugano Investigation, the Company determined that a triggering event had occurred as of December 31, 2021 and December 31, 2022 and performed impairment testing of the goodwill and definite lived intangibles at Lugano as of these dates.
ADJ 4Accrued expenses - Unrecorded liabilities related to inventory transactions at Lugano and accrued interest associated with the Lugano Financing Arrangements have been recorded in the consolidated balance sheets.
ADJ 5
Financing arrangements - Lugano entered into various financing arrangements with third parties that were not previously recorded in the historical financial statements of Lugano as debt. In connection with the Lugano Investigation, the Company determined that certain cash recorded as reduction of accounts receivable or purchases of inventory actually represented unrecorded financing arrangements made with third parties to purportedly jointly invest with Lugano in the purchase of a specified jewelry piece. These arrangements represent debt that has been recorded on the Company's consolidated balance sheets, and an amount of accrued interest associated with the arrangements has also been recorded. Refer to Note I - Debt for further description of the financing arrangements.
ADJ 6Noncontrolling interest - the correction of the misstatements resulted in a decrease in the balance of noncontrolling interest at Lugano, and reduced the noncontrolling income that previously had been recorded related to Lugano.
Consolidated Statement of Operations
ADJ 7Net revenues - net revenues at Lugano were overstated in each of the periods presented as a result of the recording of invalid revenue transactions or the misrepresentation of funds received as revenue.
ADJ 8Cost of revenues - cost of revenues at Lugano was overstated in each of the periods presented as a result of the recording of the cost of revenues associated with invalid revenue transactions and the misapplication of funds paid as inventory purchases.
ADJ 9Interest expense, net - interest expense associated with the Lugano financing arrangements described above have been recorded in the consolidated statement of operations in each of the periods presented.
ADJ 10
Other income (expense), net - reflects the expense recognized at Lugano related to losses resulting from the accounting for the transactions associated with the Lugano financing arrangements.
ADJ 11Income tax provision (benefit) - the income tax provision (benefit) at Lugano has been recalculated in each of the periods presented as a result of the effect of the aforementioned adjustments to the consolidated statement of operations.

The table below presents a summary of the impact of the cumulative effect of the misstatements on the opening balance of accumulated deficit and non-controlling interest as of the first period presented:
(in thousands)Accumulated
Deficit
Non-
Controlling
Interest
Balance — January 1, 2022, as reported$(314,267)$128,718 
Adjustment due to error corrections(163,733)(109,649)
Balance — January 1, 2022, as restated$(478,000)$19,069 
The tables below present the effect of these adjustments on the affected line items in the Company’s Consolidated Balance Sheets, Consolidated Statements of Operations and Consolidated Statements of Cash Flows as reported in the Company’s Annual Report on Form 10-K as of and for the years ended December 31, 2024, 2023 and 2022.
December 31, 2024
ADJ ReferenceAs ReportedAdjustmentsAs Restated
Assets
Current assets:
Cash and cash equivalents$59,727 (68)$59,659 
Accounts receivable, netADJ 1444,386 (237,214)207,172 
Inventories, netADJ 2962,408 (391,160)571,248 
Prepaid expenses and other current assetsADJ 2101,129 25,563 126,692 
Total current assets1,567,650 (602,879)964,771 
Property, plant and equipment, net244,746 — 244,746 
GoodwillADJ 3982,253 (86,337)895,916 
Intangible assets, netADJ 31,049,186 (65,790)983,396 
Other non-current assets208,587 208,593 
Total assets$4,052,422 $(755,000)$3,297,422 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable104,304 (1,065)103,239 
Accrued expensesADJ 4197,829 120,647 318,476 
Due to related parties (refer to Note Q)18,036 — 18,036 
Current portion, long-term debt15,000 1,759,290 1,774,290 
Subsidiary financing arrangementsADJ 5— 169,765 169,765 
Other current liabilities49,617 — 49,617 
Total current liabilities384,786 2,048,637 2,433,423 
Deferred income taxes119,948 (11,857)108,091 
Long-term debt (Refer to Note I)1,759,290 (1,759,290)— 
Other non-current liabilities225,334 — 225,334 
Total liabilities2,489,358 277,490 2,766,848 
Stockholders’ equity
Trust preferred shares, 50,000 authorized; 17,497 shares issued and outstanding at December 31, 2024
Series A preferred shares, no par value, 4,551 shares issued and outstanding at December 31, 2024
109,159 — 109,159 
Series B preferred shares, no par value, 6,192 shares issued and outstanding at December 31, 2024
147,906 — 147,906 
Series C preferred shares, no par value, 6,754 shares issued and outstanding at December 31, 2024
161,767 — 161,767 
Trust common shares, no par value, 500,000 authorized; 76,135 shares issued and 75,236 shares outstanding at December 31, 2024
1,289,010 — 1,289,010 
Treasury shares, at cost(18,910)— (18,910)
Accumulated other comprehensive income (loss)(5,815)478 (5,337)
Accumulated deficit(386,324)(618,651)(1,004,975)
Total stockholders’ equity attributable to Holdings1,296,793 (618,173)678,620 
Noncontrolling interestADJ 6266,271 (414,317)(148,046)
Total stockholders’ equity1,563,064 (1,032,490)530,574 
Total liabilities and stockholders’ equity$4,052,422 $(755,000)$3,297,422 
Year Ended December 31, 2024
ADJ ReferenceAs ReportedAdjustmentsAs Restated
Net revenuesADJ 7$2,198,233 $(410,220)$1,788,013 
Cost of revenuesADJ 81,197,873 (160,279)1,037,594 
Gross profit1,000,360 (249,941)750,419 
Operating expenses:
Selling, general and administrative expense587,521 — 587,521 
Management fees74,767 — 74,767 
Amortization expenseADJ 399,760 (4,943)94,817 
Impairment expense8,182 — 8,182 
Operating income (loss)230,130 (244,998)(14,868)
Other income (expense):
Interest expense, netADJ 9(106,683)(16,119)(122,802)
Amortization of debt issuance costs(4,018)— (4,018)
Loss on sale of Crosman(24,218)— (24,218)
Other income (expense), netADJ 10(3,902)(139,402)(143,304)
Income (loss) from continuing operations before income taxes91,309 (400,519)(309,210)
Provision for income taxesADJ 1149,012 (30,400)18,612 
Income (loss) from continuing operations42,297 (370,119)(327,822)
Loss from discontinued operations, net of income tax(6,905)— (6,905)
Gain on sale of discontinued operations, net of income tax11,957 — 11,957 
Net income (loss)47,349 (370,119)(322,770)
Less: Net income (loss) from continuing operations attributable to noncontrolling interest37,426 (148,451)(111,025)
Less: Net loss from discontinued operations attributable to noncontrolling interest(2,884)— (2,884)
Net income (loss) attributable to Holdings$12,807 $(221,668)$(208,861)
Amounts attributable to common shares of Holdings:
Income (loss) from continuing operations$4,871 $(221,668)$(216,797)
Loss from discontinued operations, net of income tax(4,021)— (4,021)
Gain on sale of discontinued operations, net of income tax11,957 — 11,957 
Net income (loss) attributable to Holdings$12,807 $(221,668)$(208,861)
Basic and fully diluted income (loss) per share attributable to Holdings (refer to Note K)
Continuing operations(1.25)(2.69)(3.94)
Discontinued operations0.11 — 0.11 
$(1.14)$(2.69)$(3.83)
Year Ended December 31, 2024
(in thousands)ADJ ReferenceAs ReportedAdjustmentsAs Restated
Cash flows from operating activities:
Net income$47,349 $(370,119)$(322,770)
Loss from discontinued operations, net of income tax(6,905)— (6,905)
Gain on sale of discontinued operations, net of income tax11,957 — 11,957 
Income (loss) from continuing operations42,297 (370,119)(327,822)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation expense43,891 — 43,891 
Amortization expense - intangiblesADJ 399,760 (4,943)94,817 
Amortization expense - inventory step-up5,295 — 5,295 
Amortization of debt issuance costs4,018 — 4,018 
Impairment expense8,182 — 8,182 
Loss on sale of Crosman24,218 — 24,218 
Noncontrolling stockholder stock based compensation16,345 — 16,345 
Provision for receivable and inventory reserves(7,044)2,018 (5,026)
Deferred taxes(17,879)3,761 (14,118)
Other1,171 585 1,756 
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivableADJ 1(117,742)102,802 (14,940)
InventoriesADJ 2(229,365)188,456 (40,909)
Other current and non-current assets3,132 — 3,132 
Accounts payable and accrued expensesADJ 451,091 (6,009)45,082 
Net cash used in operating activities - continuing operations(72,630)(83,449)(156,079)
Net cash provided by operating activities - discontinued operations4,993 — 4,993 
Net cash used in operating activities(67,637)(83,449)(151,086)
Cash flows from investing activities:
Acquisitions, net of cash acquired(517,856)— (517,856)
Purchases of property and equipment(56,701)— (56,701)
Proceeds from sale of businesses74,719 — 74,719 
Other investing activities(4,296)— (4,296)
Net cash used in investing activities - continuing operations(504,134)— (504,134)
Net cash provided by investing activities - discontinued operations81,684 — 81,684 
Net cash used in investing activities(422,450)— (422,450)
Year Ended December 31, 2024
(in thousands)ADJ ReferenceAs ReportedAdjustmentsAs Restated
Cash flows from financing activities:
Proceeds from the issuance of Trust common shares, net7,707 — 7,707 
Proceeds and expenses from issuance of Trust preferred shares, net114,914 — 114,914 
Purchase of treasury shares, net(9,571)— (9,571)
Borrowings under credit facility585,000 — 585,000 
Repayments under credit facility(475,000)— (475,000)
Repayments - Term Loan(10,000)— (10,000)
Subsidiary financing arrangements - borrowingsADJ 5— 153,646 153,646 
Subsidiary financing arrangements - repaymentsADJ 5— (70,196)(70,196)
Distributions paid - common shares(75,490)— (75,490)
Distributions paid - preferred shares(25,458)— (25,458)
Net proceeds provided by noncontrolling shareholders41,947 — 41,947 
Purchase of noncontrolling interest(4,490)— (4,490)
Distributions paid - Allocation Interests(48,941)— (48,941)
Other(4)— (4)
Net cash provided by financing activities100,614 83,450 184,064 
Foreign currency impact on cash(1,278)— (1,278)
Net increase decrease in cash and cash equivalents(390,751)(390,750)
Cash and cash equivalents — beginning of period 450,477 (68)450,409 
Cash and cash equivalents — end of period$59,726 $(67)$59,659 
December 31, 2023
ADJ ReferenceAs ReportedAdjustmentsAs Restated
Assets
Current assets:
Cash and cash equivalents446,684 (68)446,616 
Accounts receivable, netADJ 1308,183 (122,946)185,237 
Inventories, netADJ 2723,194 (200,685)522,509 
Prepaid expenses and other current assetsADJ 288,844 (11,075)77,769 
Current assets of discontinued operations36,915 — 36,915 
Total current assets1,603,820 (334,774)1,269,046 
Property, plant and equipment, net191,283 — 191,283 
GoodwillADJ 3859,907 (86,338)773,569 
Intangible assets, netADJ 3879,078 (70,734)808,344 
Other non-current assets195,010 195,016 
Non-current assets of discontinued operations87,883 — 87,883 
Total assets$3,816,981 $(491,840)$3,325,141 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable91,089 (381)90,708 
Accrued expensesADJ 4151,443 86,374 237,817 
Due to related parties (refer to Note Q)16,025 — 16,025 
Current portion, long-term debt10,000 1,661,879 1,671,879 
Subsidiary financing arrangementsADJ 5— 100,741 100,741 
Other current liabilities34,812 — 34,812 
Current liabilities of discontinued operations8,986 — 8,986 
Total current liabilities312,355 1,848,613 2,160,968 
Deferred income taxes118,882 (15,618)103,264 
Long-term debt (Refer to Note I)1,661,879 (1,661,879)— 
Other non-current liabilities203,207 — 203,207 
Non-current liabilities of discontinued operations1,277 — 1,277 
Total liabilities2,297,600 171,116 2,468,716 
Stockholders’ equity
Trust preferred shares, 50,000 authorized; 12,600 shares issued and outstanding at December 31, 2023
Series A preferred shares, no par value, 4,000 shares issued and outstanding at December 31, 2023
96,417 — 96,417 
Series B preferred shares, no par value, 4,000 shares issued and outstanding at December 31, 2023
96,504 — 96,504 
Series C preferred shares, no par value, 4,600 shares issued and outstanding at December 31, 2023
110,997 — 110,997 
Trust common shares, no par value, 500,000 authorized; 75,753 shares issued and 75,270 shares outstanding at December 31, 2023
1,281,303 — 1,281,303 
Treasury shares, at cost(9,339)— (9,339)
Accumulated other comprehensive income (loss)111 (108)
Accumulated deficit(249,243)(396,982)(646,225)
Total stockholders’ equity attributable to Holdings1,326,750 (397,090)929,660 
Noncontrolling interestADJ 6175,875 (265,866)(89,991)
Noncontrolling interest of discontinued operations16,756 — 16,756 
Total stockholders’ equity1,519,381 (662,956)856,425 
Total liabilities and stockholders’ equity$3,816,981 $(491,840)$3,325,141 
Year Ended December 31, 2023
ADJ ReferenceAs ReportedAdjustmentsAs Restated
Net revenuesADJ 7$1,965,017 $(275,097)$1,689,920 
Cost of revenuesADJ 81,132,014 (116,814)1,015,200 
Gross profit833,003 (158,283)674,720 
Operating expenses:
Selling, general and administrative expense502,013 — 502,013 
Management fees67,945 — 67,945 
Amortization expenseADJ 388,396 (4,822)83,574 
Impairment expense89,400 1,197 90,597 
Operating income (loss)85,249 (154,658)(69,409)
Other income (expense):
Interest expense, netADJ 9(105,179)(4,713)(109,892)
Amortization of debt issuance costs(4,038)— (4,038)
Other income (expense), netADJ 101,779 (84,893)(83,114)
Income (loss) from continuing operations before income taxes(22,189)(244,264)(266,453)
Provision for income taxesADJ 1122,639 (14,441)8,198 
Income (loss) from continuing operations(44,828)(229,823)(274,651)
Income (loss) from discontinued operations, net of income tax24,208 — 24,208 
Gain on sale of discontinued operations, net of income tax283,025 — 283,025 
Net income262,405 (229,823)32,582 
Less: Net income from continuing operations attributable to noncontrolling interest16,423 (92,184)(75,761)
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest(304)— (304)
Net income attributable to Holdings$246,286 $(137,639)$108,647 
Amounts attributable to common shares of Holdings:
Loss from continuing operations$(61,251)$(137,639)$(198,890)
Income from discontinued operations, net of income tax24,512 — 24,512 
Gain on sale of discontinued operations, net of income tax283,025 — 283,025 
Net income attributable to Holdings$246,286 $(137,639)$108,647 
Basic and fully diluted income (loss) per share attributable to Holdings (refer to Note K)
Continuing operations(1.81)(1.76)(3.57)
Discontinued operations4.27 — 4.27 
$2.46 $(1.76)$0.70 
Year Ended December 31, 2023
(in thousands)ADJ ReferenceAs ReportedAdjustmentsAs Restated
Cash flows from operating activities:
Net income$262,405 $(229,823)$32,582 
Income from discontinued operations, net of income tax24,208 — 24,208 
Gain on sale of discontinued operations, net of income tax283,025 — 283,025 
Loss from continuing operations(44,828)(229,823)(274,651)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation expense45,960 — 45,960 
Amortization expense - intangiblesADJ 388,396 (4,822)83,574 
Amortization expense - inventory step-upADJ 31,175 (1,175)— 
Amortization of debt issuance costs4,038 — 4,038 
Impairment expense89,400 1,197 90,597 
Noncontrolling stockholder stock based compensation9,451 — 9,451 
Provision for receivable and inventory reserves(62)3,235 3,173 
Deferred taxes(19,800)4,797 (15,003)
Other1,658 (107)1,551 
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivableADJ 1(19,941)28,862 8,921 
InventoriesADJ 2(65,492)102,583 37,091 
Other current and non-current assets(1,945)— (1,945)
Accounts payable and accrued expensesADJ 4(72,903)33,814 (39,089)
Net cash provided by (used in) operating activities - continuing operations15,107 (61,439)(46,332)
Net cash provided by operating activities - discontinued operations62,973 — 62,973 
Net cash provided by (used in) operating activities78,080 (61,439)16,641 
Cash flows from investing activities:
Purchases of property and equipment(55,016)— (55,016)
Proceeds from sale of businesses500,305 — 500,305 
Other investing activities(1,742)— (1,742)
Net cash provided by investing activities - continuing operations443,547 — 443,547 
Net cash provided by investing activities - discontinued operations126,956 — 126,956 
Net cash provided by investing activities570,503 — 570,503 
Cash flows from financing activities:
Proceeds from the issuance of Trust common shares, net74,259 — 74,259 
Purchase of treasury shares, net(9,339)— (9,339)
Borrowings under credit facility360,000 — 360,000 
Repayments under credit facility(515,000)— (515,000)
Repayments - Term Loan(10,000)— (10,000)
Subsidiary financing arrangements - borrowingsADJ 5— 121,806 121,806 
Subsidiary financing arrangements - repaymentsADJ 5— (60,367)(60,367)
Distributions paid - common shares(71,967)— (71,967)
Distributions paid - preferred shares(24,181)— (24,181)
Net proceeds provided by noncontrolling shareholders15,599 — 15,599 
Purchase of noncontrolling interest(41,297)— (41,297)
Distributions to noncontrolling shareholders(11,745)— (11,745)
Distributions paid - Allocation Interests(26,475)— (26,475)
Other(17)— (17)
Net cash provided by (used in) financing activities(260,163)61,439 (198,724)
Foreign currency impact on cash786 — 786 
Net increase (decrease) in cash and cash equivalents389,206 — 389,206 
Cash and cash equivalents — beginning of period 61,271 (68)61,203 
Cash and cash equivalents — end of period$450,477 $(68)$450,409 
December 31, 2022
ADJ Reference
As Reported (1)
AdjustmentsAs Restated
Assets
Current assets:
Cash and cash equivalents$52,743 (68)52,675 
Accounts receivable, netADJ 1288,901 (85,224)203,677 
Inventories, netADJ 2657,494 (96,044)561,450 
Prepaid expenses and other current assetsADJ 267,509 (14,202)53,307 
Current assets of discontinued operations143,538 — 143,538 
Total current assets1,210,185 (195,538)1,014,647 
Property, plant and equipment, net183,397 — 183,397 
GoodwillADJ 3950,111 (86,337)863,774 
Intangible assets, netADJ 3965,624 (74,358)891,266 
Other non-current assets161,850 161,857 
Non-current assets of discontinued operations378,464 — 378,464 
Total assets$3,849,631 $(356,226)$3,493,405 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable80,447 (3,362)77,085 
Accrued expensesADJ 4180,233 52,415 232,648 
Due to related parties (refer to Note Q)15,495 — 15,495 
Current portion, long-term debt10,000 — 10,000 
Subsidiary financing arrangementsADJ 5— 48,160 48,160 
Other current liabilities33,957 — 33,957 
Current liabilities of discontinued operations39,700 — 39,700 
Total current liabilities359,832 97,213 457,045 
Deferred income taxes139,471 (20,414)119,057 
Long-term debt1,824,468 — 1,824,468 
Other non-current liabilities139,072 — 139,072 
Non-current liabilities of discontinued operations24,826 — 24,826 
Total liabilities2,487,669 76,799 2,564,468 
Stockholders’ equity
Trust preferred shares, 50,000 authorized; 12,600 shares issued and outstanding at December 31, 2022
Series A preferred shares, no par value, 4,000 shares issued and outstanding at December 31, 2022
96,417 — 96,417 
Series B preferred shares, no par value, 4,000 shares issued and outstanding at December 31, 2022
96,504 — 96,504 
Series C preferred shares, no par value, 4,600 shares issued and outstanding at December 31, 2022
110,997 — 110,997 
Trust common shares, no par value, 500,000 authorized; 72,203 shares issued and outstanding at December 31, 2022
1,207,044 — 1,207,044 
Accumulated other comprehensive income (loss)(1,136)— (1,136)
Accumulated deficit(372,906)(259,343)(632,249)
Total stockholders’ equity attributable to Holdings1,136,920 (259,343)877,577 
Noncontrolling interestADJ 6187,444 (173,682)13,762 
Noncontrolling interest of discontinued operations37,598 — 37,598 
Total stockholders’ equity1,361,962 (433,025)928,937 
Total liabilities and stockholders’ equity$3,849,631 $(356,226)$3,493,405 
Year Ended December 31, 2022
ADJ ReferenceAs Reported AdjustmentsAs Restated
Net revenuesADJ 7$1,920,695 $(163,886)$1,756,809 
Cost of revenuesADJ 81,192,073 (84,695)1,107,378 
Gross profit728,622 (79,191)649,431 
Operating expenses:
Selling, general and administrative expense441,628 — 441,628 
Management fees62,104 — 62,104 
Amortization expenseADJ 377,237 (4,584)72,653 
Impairment expenseADJ 3— 28,602 28,602 
Operating income (loss)147,653 (103,209)44,444 
Other income (expense):
Interest expense, netADJ 9(83,481)(1,778)(85,259)
Amortization of debt issuance costs(3,740)— (3,740)
Loss on debt extinguishment(534)— (534)
Other income (expense), netADJ 10(2,314)(66,533)(68,847)
Income (loss) from continuing operations before income taxes57,584 (171,520)(113,936)
Provision for income taxesADJ 1141,367 (11,874)29,493 
Income (loss) from continuing operations16,217 (159,646)(143,429)
Income from discontinued operations, net of income tax25,831 — 25,831 
Gain on sale of discontinued operations, net of income tax9,393 — 9,393 
Net income51,441 (159,646)(108,205)
Less: Net loss from continuing operations attributable to noncontrolling interest13,793 (64,033)(50,240)
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest1,258 — 1,258 
Net income (loss) attributable to Holdings$36,390 $(95,613)$(59,223)
Amounts attributable to common shares of Holdings:
Income (loss) from continuing operations$2,424 $(95,613)$(93,189)
Income from discontinued operations, net of income tax24,573 — 24,573 
Gain on sale of discontinued operations, net of income tax9,393 — 9,393 
Net income (loss) attributable to Holdings$36,390 $(95,613)$(59,223)
Basic and fully diluted income (loss) per share attributable to Holdings (refer to Note K)
Continuing operations(0.53)(1.28)(1.81)
Discontinued operations0.43 0.01 0.44 
$(0.10)$(1.27)$(1.37)
Year Ended December 31, 2022
(in thousands)ADJ ReferenceAs Reported AdjustmentsAs Restated
Cash flows from operating activities:
Net income (loss)$51,441 $(159,646)$(108,205)
Income from discontinued operations, net of income tax25,831 — 25,831 
Gain on sale of discontinued operations, net of income tax9,393 — 9,393 
Income (loss) from continuing operations16,217 (159,646)(143,429)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation expense39,476 — 39,476 
Amortization expense - intangiblesADJ 377,237 (4,584)72,653 
Amortization expense - inventory step-upADJ 36,113 (5,483)630 
Amortization of debt issuance costs3,740 — 3,740 
Impairment expense— 28,602 28,602 
Loss on debt extinguishment534 — 534 
Noncontrolling stockholder stock based compensation10,519 — 10,519 
Provision for receivable and inventory reserves(689)4,238 3,549 
Deferred taxes3,023 — 3,023 
Other2,338 2,342 
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivableADJ 1(43,420)59,672 16,252 
InventoriesADJ 2(146,220)20,125 (126,095)
Other current and non-current assets(12,772)— (12,772)
Accounts payable and accrued expensesADJ 4(7,299)38,720 31,421 
Net cash provided by (used in) operating activities - continuing operations(51,203)(18,352)(69,555)
Net cash provided by operating activities - discontinued operations22,910 — 22,910 
Net cash provided by (used in) operating activities(28,293)(18,352)(46,645)
Cash flows from investing activities:
Acquisitions, net of cash acquired(569,028)— (569,028)
Purchases of property and equipment(60,183)— (60,183)
Proceeds from sale of businesses9,393 — 9,393 
Other investing activities(1,102)— (1,102)
Net cash provided by (used in) investing activities - continuing operations(620,920)— (620,920)
Net cash provided by (used in) investing activities - discontinued operations(5,803)— (5,803)
Net cash provided by (used in) investing activities(626,723)— (626,723)
Year Ended December 31, 2022
(in thousands)ADJ ReferenceAs Reported AdjustmentsAs Restated
Cash flows from financing activities:
Proceeds from the issuance of Trust common shares, net83,851 — 83,851 
Issuance of Term Loan400,000 — 400,000 
Borrowings under credit facility268,000 — 268,000 
Repayments under credit facility(113,000)— (113,000)
Repayments - Term Loan(5,000)— (5,000)
Subsidiary financing arrangements - borrowingsADJ 5— 60,499 60,499 
Subsidiary financing arrangements - repaymentsADJ 5— (42,147)(42,147)
Distributions paid - common shares(70,845)— (70,845)
Distributions paid - preferred shares(24,181)— (24,181)
Net proceeds provided by noncontrolling shareholders1,312 — 1,312 
Net proceeds provided by noncontrolling shareholders35,263 — 35,263 
Debt issuance costs(5,276)— (5,276)
Distributions to noncontrolling shareholders(11,292)— (11,292)
Purchase of noncontrolling interest(1,957)— (1,957)
Other10 — 10 
Net cash provided by (used in) financing activities556,885 18,352 575,237 
Foreign currency impact on cash(1,331)— (1,331)
Net increase (decrease) in cash and cash equivalents(99,462)— (99,462)
Cash and cash equivalents — beginning of period 160,733 (68)160,665 
Cash and cash equivalents — end of period$61,271 $(68)$61,203 
Lugano - Adjustments to Lugano Purchase Price Allocation
In addition to the restatement of the consolidated financial statements for the fiscal years ended December 31, 2024, 2023 and 2022, the Lugano Investigation also identified unrecorded financing arrangements and misstatements in revenue and cost of revenues in the period from acquisition of Lugano on September 3, 2021 through December 31, 2021, and errors in the balances of accounts receivable, inventory, other current assets, accounts payable, accrued expenses and unrecorded financing arrangements as of September 3, 2021 and the periods ended September 30, 2021 and December 31, 2021. As a result, the Company reperformed the September 3, 2021 purchase price allocation related to the acquisition of Lugano. The results of the revised purchase price allocation are presented below.
Purchase Price Allocation - 9/3/21Purchase Price Allocation - 9/3/21
As ReportedAdjustmentsAs Restated
Purchase consideration$265,134 — $265,134 
Fair value of identifiable assets acquired:
Cash$1,433 $(68)$1,365 
Accounts Receivable20,954 (17,602)3,352 
Inventory95,213 (58,505)36,708 
Property, plant & equipment3,135 — 3,135 
Intangible assets82,454 (78,155)4,299 
Other current and noncurrent assets9,093 (2,235)6,858 
Total identifiable assets212,282 (156,565)55,717 
Fair value of liabilities assumed:
Current liabilities7,187 39,362 46,549 
Other liabilities3,175 — 3,175 
Deferred tax liabilities23,123 (21,693)1,430 
Total liabilities33,485 17,669 51,154 
Net identifiable assets acquired178,797 (174,234)4,563 
Goodwill$86,337 $174,234 $260,571 
Intangible AssetsFair ValueFair Value
As ReportedAdjustmentsAs Restated
Tradename$48,433 $(48,207)$226 
Customer Relationships34,021 (29,948)4,073 
$82,454 $(78,155)$4,299 
Lugano - Interim Impairment Testing
The Company performed an interim impairment test of goodwill at Lugano as of December 31, 2021. Historical information that had previously been relied on by the Company in preparing projected financial information for the period ending December 31, 2021 proved to be inaccurate, and operating results were below forecast amounts that were used as the basis for the purchase price allocation performed when Lugano was acquired. Therefore the Company determined that a triggering event had occurred. The Company performed the quantitative impairment test using an income approach. The prospective information used in the income approach considered macroeconomic data, industry and reporting unit specific facts and circumstances and was our best estimate of operational results and cash flows for the Lugano reporting unit as of the date of our impairment testing. The discount rate used in the income approach was 12.0% The results of the quantitative impairment testing indicated that the fair value of the Lugano reporting unit did not exceed its carrying value, resulting in goodwill impairment expense of $237.2 million in the year ended December 31, 2021.